期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

瑞舒伐他汀对经皮冠状动脉介入治疗患者术后炎症反应与心肌损伤的影响 被引量：10

下载PDF
导出
摘要 急性冠状动脉综合征（ACS）患者采用经皮冠状动脉介入治疗（PCI）已经成为冠状动脉血运重建的最佳手段之一。ACS的发病与冠状动脉局部斑块病变不稳定和炎症反应有关。PCI本身可能会引起血管壁的损伤和炎症反应，进而引起心肌损伤。
作者 马晓峰 高琴 边惠萍 刘品发
机构地区 青海省心脑血管病专科医院心内科
出处 《临床荟萃》 CAS 2013年第9期1042-1044,共3页 Clinical Focus
关键词 冠状动脉疾病 心肌再灌注损伤 炎症 瑞舒伐他汀 磁共振成像 介入性
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献11

  • 1Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al. Determinants of arterial wall remodeling during lipid-lowering therapy:serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy(REVERSAL) trial [ J ]. Circulation, 2006, 113 ( 24 ) : 2826-2834.
  • 2Rebeiz AG, Zoghbi E, Harb R, et al. Comparisott of the systemic levels of inflammatory markers after percutaneous coronary intervention with bare metal versus sirolimus-eluting stents[J]. J Interv Cardiol, 2009,22(2) : 169-174.
  • 3应佐华,应佑国,边惠萍,杨良瑞.高海拔地区不稳定型心绞痛PCI术前应用强化阿托伐他汀治疗的疗效[J].医学临床研究,2012,29(12):2275-2277. 被引量：3
  • 4Ray KK, Cannon CP. The potential relevance of the mutiple lipid-independent ( pleiotropic ) effects of statins in the managment of acute coronary syndromes [J ]. J Am Coil Cardiol, 2005,46(8) : 1425-1433.
  • 5Nicholls SJ, Brandrup-Wognsen G, Palmer M, et al. Meta- analysis of comparative efficacy of increasing dose of Atorvastatln versus Rosuvasmtin versus Simvastation on lowering levels of atherogenic lipids (from VOYAGER) [J]. Am J Cardiol,2010,105(1):69 -76.
  • 6常快乐,王海昌,陶凌,贾敏,廉坤,刘毅,杨璐,马新亮.强化他汀治疗对经皮冠状动脉介入术患者冠状动脉无复流及血浆相关因子的影响[J].临床内科杂志,2012,29(9):606-609. 被引量：7
  • 7Takayama T, Hiro T, Yamagishi M, et al. Etfect of rOsuvastatin on coronary atheroma in stable coronary artery disease: multicenter coronary atherosclerosis study measuring et'fects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS)[J]. Circ J,2009,73 (11) : 2110- 2117.
  • 8Grouse JR 3rd, RaichIen JS, Riley WA, et al. Effect oI rosuvastatin on progression of carotid intima media thickness in low-risk individuals with subclinical atheroselerosis: the METEOR Trial [J].JAMA,2007,297(12) :1344 -1353.
  • 9廖玉华.经皮冠状动脉介入治疗术前的负荷剂量他汀类药物治疗[J].临床心血管病杂志,2011,27(1):1-3. 被引量：10
  • 10Brewer HB Jr. Benefit-risk assessment of rosuvastatin 10 to dO milligrams[J]. Am J Cardioh2003,92(4B) :23K-29K.

二级参考文献26

  • 1马绍椿,徐新,唐良秋,叶小兰,肖全华.阿托伐他汀对血脂正常的稳定性心绞痛患者的抗心肌缺血作用[J].中国医师杂志,2004,6(7):1002-1003. 被引量：4
  • 2栾荣华 吕树铮.ARMYDA系列研究显示,术前给予阿托伐他汀显著降低PCI围手术期不良事件危险.中国医学论坛报,2007,:33-33,18.
  • 3YUN K H, JEONG M H, KYU S, et al. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome[J]. Int J Cardiol,2009,137 : 246-251.
  • 4VESELKA J, ZEMANEK D, HAJEK P, et al Effect of two-day atorvastatin pretreatment on the Incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study[J]. Am J Cardiol,2009,104:630-633.
  • 5NICHOLLS S J, BRANDRUP-WOGNSEN G, PALMER M, et al. Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosuvastatin versus Simvastatin on lowering levels of atherogenie lipids (from VOYAGER) [J]. Am J Cardiol,2010,105: 69-76.
  • 6胡大一,马长生.心脏病学实践[M].北京:人民:卫生出版社,2007.200-203.
  • 7Schoenhagen P, Tuzcu EM, Apperson-Hansen C, et al. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascu?lar ultrasound observations from the reversal of atherosclerosis with ag?gressive lipid lowering therapy ( REVERSAL) trial. Circulation, 2006, 113 :2816-2814.
  • 8Gibson CM, Schomig A. Coronary and myocardial angiograph: angio?graphic assessment of both epieardial perfusion. Circulation ,2004,109: 3096-3105.
  • 9Germano DS, Giuseppe P , Vincenzo P , et al. Efficacy of atorvastatin re?load in patients on chronic statin therapy undergoing percutaneous coro?nary intervention. J Am ColI Cardiol, 2009 ,54 : 558 -565.
  • 10Briguori C, Visconti G, Focaccio A, et al. Novel Approaches for Preven?ting or Limiting Events (Naples) II Trial: Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction. J Am Coll Cardiol ,2009,54 :2157 - 2163.

共引文献17

同被引文献102

  • 1程翔,廖玉华,李彬,杨亚利,张金盈,逯保军,葛洪霞,刘英,郭张强,张玲.早期美托洛尔治疗对急性心肌梗死大鼠心肌炎症因子表达和心功能的影响[J].中华心血管病杂志,2005,33(5):448-452. 被引量：44
  • 2马永娜,李拥军,赵伟,张辉,杨蓉,苏便苓.白细胞介素6与急性心肌梗死后心室重构的相关性[J].临床荟萃,2005,20(23):1326-1328. 被引量：6
  • 3陈立生.血脂康早期干预对急性冠脉综合征患者炎症因子的影响[J].实用医学杂志,2007,23(17):2738-2739. 被引量：5
  • 4Kaikita, Hayasaki T, Okuma T, et al. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction [ J ]. Am J pathol, 2004,165(2) :439.
  • 5Ohara Y, Hiasa Y,Hosokawa S,et al. Impact of hydroxy methylglutaryl coenzyme A reductase inhibition on left ven- tricular remodeling in patients with acute anterior myocardial infarction after primary coronary angioplasty [ J ]. Int Heart J, 2005,46(6) :987.
  • 6颜红兵,朱小玲.美国sT段抬高心肌梗死治疗指南[M].北京:中国环境科学出版社,2005.
  • 7Kaikita, HayasakiT, OkumaT, et al. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimentM myocardial infarction [J]. Am J pathol, 2004,165 (2) :439-447.
  • 8Ohara Y, Hiasa Y, Hosokawa S et al. Impact of hydroxy methylglutaryl coenzyme A reductase inhibition on left ventricular remodeling in patients with acute anterior myocardial infarction after primary coronary angioplasty [ J ]. Int Heart J,2005,45 (6) : 987 -995.
  • 9颜红兵,朱小玲主译.美国ST段抬高心肌梗死治疗指南(M)中国环境科学出版社, 2005
  • 10黄根牙,顾新元,唐利龙.急性心肌梗死后早期心功能的变化及其调节机制[J].心血管病学进展,2008,29(6):851-854. 被引量：9

引证文献10

二级引证文献91

临床荟萃
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部